CROX Stock Analysis: Crocs | NASDAQ
Footwear & Accessories | NASDAQ, USA | Market Cap: 6.315m USD | 12M Return: 58.9% | US2270461096 | Charts, Fundamentals & Technical Analysis
Avg Turnover: 125M
EPS Trend: 30.1%
Qual. Beats: 17
Rev. Trend: 49.8%
Qual. Beats: 4
Warnings
No concerns identified
Tailwinds
Seasonality 11.6 years of data
How good or bad each month usually is (without trend). The score below shows how much you can trust it: 0 = pure chance, >40 gets interesting and >55 is strong.
Crocs, Inc. (CROX) is a U.S.-based casual lifestyle footwear and accessories company that designs, manufactures, markets, and distributes products for men, women, and children under two flagship brands: Crocs and HEYDUDE, with sales spanning domestic and international markets. Its product portfolio is broad within the casual footwear category, spanning clogs, sandals, loafers, boots, slides, sneakers, slippers, and flats, alongside accessories such as totes, backpacks, socks, and bag charms. The company operates a multi-channel distribution model that combines wholesale, company-owned retail stores, e-commerce sites, third-party marketplaces, outlet stores, and kiosk/store-in-store locations, which is typical of branded footwear players seeking both scale and direct-to-consumer reach. Crocs was founded in 1999, is headquartered in Broomfield, Colorado, and trades on NASDAQ as a mid-cap stock within the Consumer Discretionary / Footwear segment of the GICS classification.
- HEYDUDE brand revenue growth decelerates amid weakened consumer demand
- Vietnam manufacturing tariffs compress gross margins
- Aggressive share buybacks accelerate capital return program
| Net Income: 593.4m TTM > 0 and > 6% of Revenue |
| FCF/TA: 0.16 > 0.02 and ΔFCF/TA -1.10 > 1.0 |
| NWC/Revenue: 8.79% < 20% (prev 9.35%; Δ -0.56% < -1%) |
| CFO/TA 0.18 > 3% & CFO 762.6m > Net Income 593.4m |
| Net Debt (1.90b) to EBITDA (887.4m): 2.14 < 3 |
| Current Ratio: 1.49 > 1.5 & < 3 |
| Outstanding Shares: last quarter (50.2m) vs 12m ago -10.07% < -2% |
| Gross Margin: 57.47% > 18% (prev 59.36%; Δ -1.89% > 0.5%) |
| Asset Turnover: 92.08% > 50% (prev 92.99%; Δ -0.91% > 0%) |
| Interest Coverage Ratio: 6.81 > 6 (EBIT TTM 846.2m / Interest Expense TTM 124.3m) |
| A: 0.08 (Total Current Assets 1.08b - Total Current Liabilities 728.0m) / Total Assets 4.36b |
| B: 0.88 (Retained Earnings 3.82b / Total Assets 4.36b) |
| C: 0.19 (EBIT TTM 846.2m / Avg Total Assets 4.40b) |
| D: 0.47 (Book Value of Equity 1.38b / Total Liabilities 2.97b) |
| Altman-Z'' = 5.18 = AAA |
| DSRI: 1.04 (Receivables 453.2m/446.1m, Revenue 4.05b/4.14b) |
| GMI: 1.03 (GM 59.36% / 57.47%) |
| AQI: 1.00 (AQ_t 0.62 / AQ_t-1 0.62) |
| SGI: 0.98 (Revenue 4.05b / 4.14b) |
| TATA: -0.04 (NI 593.4m - CFO 762.6m) / TA 4.36b) |
| Beneish M = -2.99 (Cap -4..+1) = A |
As of August 17, 2026, the stock is trading at USD 131.72 with a total of 742,883 shares traded. Over the past week, the price has changed by -3.59%, over one month by -5.18%, over three months by +35.79% and over the past year by +58.93%.
Current recommended Stop Loss: 124.40 (which is 5.6% or 1.3 ATR below the current price).
Crocs has received a consensus analysts rating of 3.47. Therefore, it is recommended to hold CROX.
- StrongBuy: 4
- Buy: 1
- Hold: 9
- Sell: 0
- StrongSell: 1
| Analysts Target Price | 138.3 | 5% |
P/E Trailing = 11.6773
P/E Forward = 9.5147
P/S = 1.5575
P/B = 4.5609
P/EG = 1.3926
Revenue TTM = 4.05b USD
EBIT TTM = 846.2m USD
EBITDA TTM = 887.4m USD
Long Term Debt = 1.31b USD (from longTermDebt, last quarter)
Short Term Debt = 90.1m USD (from shortTermDebt, last quarter)
Debt = 2.07b USD (from shortLongTermDebtTotal, last quarter) + Leases 381.5m
Net Debt = 1.90b USD (calculated: Debt 2.07b - CCE 170.3m)
Enterprise Value = 8.22b USD (6.32b + Debt 2.07b - CCE 170.3m)
Interest Coverage Ratio = 6.81 (Ebit TTM 846.2m / Interest Expense TTM 124.3m)
EV/FCF = 11.66x (Enterprise Value 8.22b / FCF TTM 704.6m)
FCF Yield = 8.58% (FCF TTM 704.6m / Enterprise Value 8.22b)
FCF Margin = 17.38% (FCF TTM 704.6m / Revenue TTM 4.05b)
Net Margin = 14.63% (Net Income TTM 593.4m / Revenue TTM 4.05b)
Gross Margin = 57.47% ((Revenue TTM 4.05b - Cost of Revenue TTM 1.72b) / Revenue TTM)
Gross Margin QoQ = 59.41% (prev 56.75%)
Tobins Q-Ratio = 1.89 (Enterprise Value 8.22b / Total Assets 4.36b)
Interest Expense / Debt = 6.00% (Interest Expense 124.3m / Debt 2.07b)
Taxrate = 21.86% (166.0m / 759.4m)
NOPAT = 661.2m (EBIT 846.2m * (1 - 21.86%))
Current Ratio = 1.49 (Total Current Assets 1.08b / Total Current Liabilities 728.0m)
Debt / Equity = 1.50 (Debt 2.07b / totalStockholderEquity, last quarter 1.38b)
Debt / EBITDA = 2.14 (Net Debt 1.90b / EBITDA 887.4m)
Debt / FCF = 2.70 (Net Debt 1.90b / FCF TTM 704.6m)
Total Stockholder Equity = 1.37b (last 4 quarters mean from totalStockholderEquity)
RoA = 13.48% (Net Income 593.4m / Total Assets 4.36b)
RoE = 43.41% (Net Income TTM 593.4m / Total Stockholder Equity 1.37b)
RoCE = 31.63% (EBIT 846.2m / Capital Employed (Equity 1.37b + L.T.Debt 1.31b))
RoIC = 18.64% (NOPAT 661.2m / Invested Capital 3.55b)
WACC = 8.82% (E(6.32b)/V(8.39b) * Re(10.18%) + D(2.07b)/V(8.39b) * Rd(6.00%) * (1-Tc(0.22)))
Discount Rate = 10.18% (= CAPM, Blume Beta Adj.)
Shares (quarterly) Correlation: -99.28 | Cagr: -8.36%
[DCF] Terminal Value 72.51% ; FCFF base≈730.3m ; Y1≈681.9m ; Y5≈624.5m
[DCF] Fair Price = 151.1 (EV 9.15b - Net Debt 1.90b = Equity 7.24b / Shares 47.9m; r=8.82% [WACC]; 5y FCF grow -8.36% → 2.50% )
EPS Correlation: 30.12 | EPS CAGR: 1.16% | SUE: 1.64 | # QB: 17
Revenue Correlation: 49.83 | Revenue CAGR: 0.77% | SUE: 2.46 | # QB: 4
EPS current Quarter (2026-09-30): EPS=3.30 | Chg30d=-6.91% | Revisions=-81% | Analysts=14
EPS current Year (2026-12-31): EPS=13.95 | Chg30d=+2.08% | Revisions=+82% | GrowthEPS=+11.5% | GrowthRev=+1.5%
EPS next Year (2027-12-31): EPS=14.95 | Chg30d=+2.93% | Revisions=+82% | GrowthEPS=+7.2% | GrowthRev=+2.5%
[Analyst] Revisions Ratio: +34% (up=28, down=13)